Appeals Court Upholds Procter & Gamble Patent Rights On Actonel
WASHINGTON -(Dow Jones)- A US appeals court Wednesday upheld a lower court ruling that protected Procter & Gamble Co.’s (PG) patent rights to osteoporosis drug Actonel, which were under attack from generic competitor Teva Pharmaceuticals Industries …
Read more at:
CNNMoney.com >>>
No related posts.